A new FDA draft guidance recommends sponsors include new class labeling and prescribing information for combined hormonal contraceptives containing estrogen and progestin. Source: Drug Industry Daily
Menlo Therapeutics filed on Thursday with the SEC to raise up to $98M in an IPO. Source: BioSpace
ANI Phamaceuticals funded the acquisitions through a combination of cash and debt. Source: BioSpace
A look at a few biotechs which should outperform the market in 2018: Source: BioSpace
The parts expect the closing in the first quarter 2018. Source: BioSpace
The company's sales department will take the brunt of the layoffs, losing 235 jobs. Source: BioSpace
Celgene announced back in October that it was discontinuing its GED-0301 program for Crohn's disease and now that decision is costing the company $411M. Source: BioSpace
The J.P. Morgan Healthcare Conference is held every year in early January, and this year it will be Jan. 8-11 in San Francisco, as usual. Source: BioSpace
Thanks to the Republican tax legislation, pharmaceutical stocks are set to continue their heady northward trajectory in 2018. Source: BioSpace
The drug showed a significant, clinically meaningful and fast-acting improvement in depression symptoms compared to an intranasal placebo. Source: BioSpace